Literature DB >> 17137791

SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations.

Lei Gao1, Junning Wang, Yingzi Wang, Athena Andreadis.   

Abstract

The microtubule-associated protein tau is important to normal neuronal function in the mammalian nervous system. Aggregated tau is the major component of neurofibrillary tangles (NFTs), present in several neurodegenerative diseases, including Alzheimer's and frontotemporal dementia with Parkinsonism (FTDP). Splicing misregulation of adult-specific exon 10 results in expression of abnormal ratios of tau isoforms, leading to FTDP. Positions +3 to +16 of the intron downstream of exon 10 define a clustering region for point mutations that are found in FTDP. The serine/arginine-rich (SR) factor 9G8 strongly inhibits inclusion of tau exon 10. In this study, we established that 9G8 binds directly to this clustering region, requires a wild-type residue at position +14 to inhibit exon inclusion, and RNAi constructs against 9G8 increase exon 10 inclusion. These results indicate that 9G8 plays a key role in regulation of exon 10 splicing and imply a pathogenic role in neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17137791      PMCID: PMC1866282          DOI: 10.1016/j.mcn.2006.10.004

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  53 in total

1.  Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion.

Authors:  I D'Souza; G D Schellenberg
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

Review 2.  Alternative splicing: increasing diversity in the proteomic world.

Authors:  B R Graveley
Journal:  Trends Genet       Date:  2001-02       Impact factor: 11.639

3.  SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.

Authors:  X Li; M E Shambaugh; F M Rottman; J A Bokar
Journal:  RNA       Date:  2000-12       Impact factor: 4.942

4.  Alternative splicing of intron 3 of the serine/arginine-rich protein 9G8 gene. Identification of flanking exonic splicing enhancers and involvement of 9G8 as a trans-acting factor.

Authors:  F Lejeune; Y Cavaloc; J Stevenin
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

Review 5.  Alternative pre-mRNA splicing: the logic of combinatorial control.

Authors:  C W Smith; J Valcárcel
Journal:  Trends Biochem Sci       Date:  2000-08       Impact factor: 13.807

Review 6.  Messenger-RNA-binding proteins and the messages they carry.

Authors:  Gideon Dreyfuss; V Narry Kim; Naoyuki Kataoka
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

7.  tau Exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5' and 3' splice sites.

Authors:  Ian D'Souza; Gerard D Schellenberg
Journal:  J Biol Chem       Date:  2002-05-08       Impact factor: 5.157

Review 8.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

9.  Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17.

Authors:  Z Jiang; J Cote; J M Kwon; A M Goate; J Y Wu
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

10.  Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors.

Authors:  A M Hartmann; D Rujescu; T Giannakouros; E Nikolakaki; M Goedert; E M Mandelkow; Q S Gao; A Andreadis; S Stamm
Journal:  Mol Cell Neurosci       Date:  2001-07       Impact factor: 4.314

View more
  31 in total

1.  PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.

Authors:  Payal Ray; Amar Kar; Kazuo Fushimi; Necat Havlioglu; Xiaoping Chen; Jane Y Wu
Journal:  J Mol Neurosci       Date:  2011-09-01       Impact factor: 3.444

Review 2.  Tau splicing and the intricacies of dementia.

Authors:  Athena Andreadis
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

3.  An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.

Authors:  Yan Wang; Junning Wang; Lei Gao; Stefan Stamm; Athena Andreadis
Journal:  Gene       Date:  2011-06-30       Impact factor: 3.688

Review 4.  Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Biochem Pharmacol       Date:  2014-01-10       Impact factor: 5.858

5.  RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site.

Authors:  Amar Kar; Kazuo Fushimi; Xiaohong Zhou; Payal Ray; Chen Shi; Xiaoping Chen; Zhiren Liu; She Chen; Jane Y Wu
Journal:  Mol Cell Biol       Date:  2011-02-22       Impact factor: 4.272

6.  The human MAPT locus generates circular RNAs.

Authors:  Justin R Welden; Jacob van Doorn; Peter T Nelson; Stefan Stamm
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-03       Impact factor: 5.187

7.  Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.

Authors:  Jianlan Gu; Feng Chen; Khalid Iqbal; Cheng-Xin Gong; Xinglong Wang; Fei Liu
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

8.  Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease.

Authors:  Jianhua Shi; Wei Qian; Xiaomin Yin; Khalid Iqbal; Inge Grundke-Iqbal; Xiaosong Gu; Fei Ding; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

9.  The cardiotonic steroid digitoxin regulates alternative splicing through depletion of the splicing factors SRSF3 and TRA2B.

Authors:  Erik S Anderson; Chia-Ho Lin; Xinshu Xiao; Peter Stoilov; Christopher B Burge; Douglas L Black
Journal:  RNA       Date:  2012-03-28       Impact factor: 4.942

10.  A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators.

Authors:  Peter Stoilov; Chia-Ho Lin; Robert Damoiseaux; Julia Nikolic; Douglas L Black
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.